Colgate-Palmolive (India) Limited share price
NSE: COLPAL · ISIN INE259A01022
Key numbers
- Market cap
- ₹ 50,475 Cr
- Current price
- ₹ 1,855.80
- 52-week high / low
- ₹ 2,330 / 1,782
- Stock P/E
- 37.5
- Book value
- ₹ 58.2
- Dividend yield
- 2.59%
- ROCE
- 106.5%
- ROE
- 81.6%
- Debt to equity
- 0.03
- Sales growth (3 yrs)
- 4.9%
- Profit growth (3 yrs)
- 8.2%
- 1-year return
- -20.0%
About Colgate-Palmolive (India) Limited
Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, serum, rinses, whitening products, hand washes, and shower gels under the Colgate and Palmolive brand name. It also offers soaps, cosmetics, and toiletries. In addition, the company exports its products. Colgate-Palmolive (India) Limited was incorporated in 1937 and is headquartered in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 1,452 | 1,421 | 1,473 | 1,583 | 1,591 |
| Operating profit | 498 | 453 | 442 | 510 | 483 |
| Net profit | 355 | 321 | 324 | 353 | 343 |
| EPS (₹) | 13.05 | 11.79 | 11.91 | 12.99 | 12.61 |
Concall summary (2026-08-21)
AI summary of the earnings call transcript · tone: Positive · source document
Guidance & outlook
- So if you look at our margin profile over the last few years, if you take the first block FY21 to FY23, where in the to 68% levels, and if you look at FY24 to FY26, to 70%, and Q1, we reported 69.7%.
- This year we expect it will be 12-10%, roughly more than the million children.
Growth & demand
- And you saw we are growing at 6X and we need to continue the premium growth because ASPs you know, 2X-3X.
- But despite doing exceptionally 20% kind of growth, I just do the rough maths and then comes in pricing and mix.
Margins & costs
- But going beyond that, we talked about the recyclable tubes 100%; now technology that we've developed and we've opened it up to a competitor free of cost now.
- There will be good years on pricing and there will be not so good years on pricing depending on what competition does, what inflation does, what the market overall does.
Capex & expansion
- And for this, we are doing a massive amount of investment in both sampling as well as increasing our feet on street or increasing our oral care experts who go to dentists.
- And how did we deliver this, identifying manufacturing efficiencies, localization of sourcing that's replacing imported material with local material, automation initiatives at the plant and right through the supply chain up to the warehouses and favourable product mix.
Balance sheet & cash
- Our balance sheet continues to be as strong as it was ever, bolstered by efficient working capital, and our networking capital continues to inch further lower in terms of the negative per cent to sales and sustained cash generation.
- Dividend payout has been consistent over the years and since, listing at 22% CAGR, we've given very good returns to the shareholders.
Peers in Household & Personal Products
Data for information only, not investment advice. Prices end of day.